Europe Typhoid Fever Vaccines Market
The Europe Typhoid Fever Vaccines Market size was valued at US$ 74.43 Mn in 2019 and is projected to reach US$ 145.36 Mn by 2027, growing at a CAGR of 9.0% during 2020 - 2027.
Report Coverage
- Vaccine Type: Live Attenuated Vaccine, Capsular Polysaccharide Vaccines, Conjugate Vaccine
- Route of administration: Oral and Injectable
US$ 74.43 Mn
Market size in 2019
US$ 145.36 Mn
Market Size by 2027
9.0%
CAGR, 2020 - 2027
2020-2027
Forecast Period
1. Introduction
1.1 Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Market Insights
2.2 Market Attractiveness
3. Research Methodology
3.1 Secondary Research
3.2 Primary Research
- 3.2.1 Data Triangulation and Validation
4. Europe Typhoid Fever Vaccines Market Landscape
4.1 Overview
4.3 Ecosystem Analysis
- 4.3.1 List of Vendors in the Value Chain
5. Europe Typhoid Fever Vaccines Market – Key Market Dynamics
5.1 Market Drivers
5.2 Market Restraints
5.3 Market Opportunities
5.4 Future Trends
5.5 Impact of Drivers and Restraints
6. Europe Typhoid Fever Vaccines Market Regional Analysis
6.2 Europe Typhoid Fever Vaccines Market Revenue 2017-2027 (US$ Million)
6.3 Europe Typhoid Fever Vaccines Market Forecast Analysis
7. Europe Typhoid Fever Vaccines Market Analysis – by Vaccine Type
7.1 Live Attenuated Vaccine
- 7.1.1 Overview
- 7.1.2 Live Attenuated Vaccine: Europe Typhoid Fever Vaccines Market – Revenue and Forecast, 2017-2027 (US$ Million)
7.2 Capsular Polysaccharide Vaccines
- 7.2.1 Overview
- 7.2.2 Capsular Polysaccharide Vaccines: Europe Typhoid Fever Vaccines Market – Revenue and Forecast, 2017-2027 (US$ Million)
7.3 Conjugate Vaccine
- 7.3.1 Overview
- 7.3.2 Conjugate Vaccine: Europe Typhoid Fever Vaccines Market – Revenue and Forecast, 2017-2027 (US$ Million)
8. Europe Typhoid Fever Vaccines Market Analysis – by Route of administration
8.1 Oral and Injectable
- 8.1.1 Overview
- 8.1.2 Oral and Injectable: Europe Typhoid Fever Vaccines Market – Revenue and Forecast, 2017-2027 (US$ Million)
9. Europe Typhoid Fever Vaccines Market – Europe Analysis
9.1 Overview
9.2 Europe- 9.2.1 Europe Typhoid Fever Vaccines Market Breakdown, by Key Country, 2020 and 2027 (%)
- 9.2.1.1 Europe Typhoid Fever Vaccines Market – Revenue and Forecast Analysis – by Country
- 9.2.1.1 UK: Europe Typhoid Fever Vaccines Market – Revenue and Forecast to 2027 (US$ Million)
- 9.2.1.1.1 UK: Europe Typhoid Fever Vaccines Market Breakdown, by Vaccine Type
- 9.2.1.1.2 UK: Europe Typhoid Fever Vaccines Market Breakdown, by Route of administration
- 9.2.1.2 Germany: Europe Typhoid Fever Vaccines Market – Revenue and Forecast to 2027 (US$ Million)
- 9.2.1.2.1 Germany: Europe Typhoid Fever Vaccines Market Breakdown, by Vaccine Type
- 9.2.1.2.2 Germany: Europe Typhoid Fever Vaccines Market Breakdown, by Route of administration
- 9.2.1.3 France: Europe Typhoid Fever Vaccines Market – Revenue and Forecast to 2027 (US$ Million)
- 9.2.1.3.1 France: Europe Typhoid Fever Vaccines Market Breakdown, by Vaccine Type
- 9.2.1.3.2 France: Europe Typhoid Fever Vaccines Market Breakdown, by Route of administration
- 9.2.1.4 Russia: Europe Typhoid Fever Vaccines Market – Revenue and Forecast to 2027 (US$ Million)
- 9.2.1.4.1 Russia: Europe Typhoid Fever Vaccines Market Breakdown, by Vaccine Type
- 9.2.1.4.2 Russia: Europe Typhoid Fever Vaccines Market Breakdown, by Route of administration
- 9.2.1.5 Italy: Europe Typhoid Fever Vaccines Market – Revenue and Forecast to 2027 (US$ Million)
- 9.2.1.5.1 Italy: Europe Typhoid Fever Vaccines Market Breakdown, by Vaccine Type
- 9.2.1.5.2 Italy: Europe Typhoid Fever Vaccines Market Breakdown, by Route of administration
- 9.2.1.6 Rest of Europe: Europe Typhoid Fever Vaccines Market – Revenue and Forecast to 2027 (US$ Million)
- 9.2.1.6.1 Rest of Europe: Europe Typhoid Fever Vaccines Market Breakdown, by Vaccine Type
- 9.2.1.6.2 Rest of Europe: Europe Typhoid Fever Vaccines Market Breakdown, by Route of administration
10. Competitive Landscape
10.1 Heat Map Analysis
10.2 Company Positioning and Concentration
11. Industry Landscape
11.1 Overview
11.2 Market Initiative
11.3 Partnerships and Collaborations
11.4 Other Developments
12. Company Profiles
12.1 Sanofi
- 12.1.1 Key Facts
- 12.1.2 Business Description
- 12.1.3 Products and Services
- 12.1.4 Financial Overview
- 12.1.5 SWOT Analysis
- 12.1.6 Key Developments
12.2 GlaxoSmithKline plc
- 12.2.1 Key Facts
- 12.2.2 Business Description
- 12.2.3 Products and Services
- 12.2.4 Financial Overview
- 12.2.5 SWOT Analysis
- 12.2.6 Key Developments
12.3 Paxvax Inc
- 12.3.1 Key Facts
- 12.3.2 Business Description
- 12.3.3 Products and Services
- 12.3.4 Financial Overview
- 12.3.5 SWOT Analysis
- 12.3.6 Key Developments
12.4 Prokarium Ltd
- 12.4.1 Key Facts
- 12.4.2 Business Description
- 12.4.3 Products and Services
- 12.4.4 Financial Overview
- 12.4.5 SWOT Analysis
- 12.4.6 Key Developments
12.5 Scandinavian Biopharma
- 12.5.1 Key Facts
- 12.5.2 Business Description
- 12.5.3 Products and Services
- 12.5.4 Financial Overview
- 12.5.5 SWOT Analysis
- 12.5.6 Key Developments
13. Appendix
13.1 About Business Market Insights
13.2 List of Abbreviations
Access the Full E Market Report
Get segment-level forecasts, regional estimates, competitive benchmarking, company profiles and downloadable Excel datasets.
